[
Ahotupa M, Ruutu M, Mantyla E. Simple methods of quantifying oxidation products and antioxidant potential of low-density lipoproteins. Clin Biochem 29, 139–144, 1996.
]Search in Google Scholar
[
Ahotupa M, Marniemi J, Lehtimaki T, Talvinen K, Raitakari OT, Vasankari T, Viikari J, Luoma J, Yla-Herttuala S. Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation. Clin Biochem 31, 257–261, 1998.
]Search in Google Scholar
[
Asghar S, Asghar S, Shahid S, Fatima M, Bukhari SMH, Nadeem Siddiqui S. Metabolic syndrome in type 2 diabetes mellitus patients: prevalence, risk factors, and associated microvascular complications. Cureus 15, e39076, 2023.
]Search in Google Scholar
[
Barre DE, Mizier-Barre KA, Griscti, O, Hafez K Gender differential in apo E genotypes’ correlative tendency to dyslipidaemia responsiveness upon flaxseed oil administration in adult type 2 diabetic patients not meeting the 2008 Canadian Practice Guidelines. Int J Diabetes Metab 18, 99–113, 2010.
]Search in Google Scholar
[
Barre DE, Mizier-Barre KA, Stelmach E, Hobson J, Griscti O, Rudiuk A, Muthuthevar D. Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis - an invitation to further investigation into polypharmacy reduction. J Nutr Metab 2012, 585170, 2012.
]Search in Google Scholar
[
Boren J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41, 2313–2330, 2020.
]Search in Google Scholar
[
Carvalho-Wells AL, Jackson KG, Lockyer S, Lovegrove JA, Minihane AM. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am J Clin Nutr 96, 1447–1453, 2012. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545–548, 1990.
]Search in Google Scholar
[
Kontush A, Chapman MJ. Why is HDL functionally deficient in type 2 diabetes? Curr Diab Rep 8, 51–59, 2008. Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L. The role of oxidative stress during inflammatory processes. Biol Chem 395, 203–230, 2014.
]Search in Google Scholar
[
Lemieux S, Prud’homme D, Bouchard C, Tremblay A, Despres JP. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 64, 685–693, 1996.
]Search in Google Scholar
[
Nishigaki I, Haghara M, Taunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 25, 373–378, 1981.
]Search in Google Scholar
[
Saito M, Eto M, Nitta H, Kanda Y, Shigeto M, Nakayama K, Tawaramoto K, Kawasaki F, Kamei S, Kohara K, Matsuda M, Matsuki M, Kaku K. Effect of apolipoprotein E4 allele on plasma LDL cholesterol response to diet therapy in type 2 diabetic patients. Diabetes Care 27, 1276–1280, 2004.
]Search in Google Scholar
[
Sapkota B, Subramanian A, Priamvada G, Finely H, Blackett PR, Aston CE, Sanghera DK. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population. J Diabetes Complications 29, 1191–1197, 2015.
]Search in Google Scholar
[
Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care 32, 525–527, 2009.
]Search in Google Scholar
[
Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 9, 754, 2018.
]Search in Google Scholar
[
Tabatabaei-Malazy O, Fakhrzadeh H, Qorbani M, Amiri P, Larijani B, Tavakkoly-Bazzaz J, Amoli MM. Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and T2D. J Diabetes Metab Disord 11, 1–7, 2012.
]Search in Google Scholar
[
Tamasawa N, Murakami H, Yamato K, Matsui J, Tanabe J, Suda T. Influence of apolipoprotein E genotype on the response to caloric restriction in type 2 diabetic patients with hyperlipidemia. Diabetes Obes Metab 5, 345–348, 2003.
]Search in Google Scholar
[
Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84, 3212–3216, 1999.
]Search in Google Scholar
[
Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 6, 456–480, 2015.
]Search in Google Scholar
[
Tavintharan S, Lim SC, Chan YH, Sum CF. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus. Diabetes Obes Metab 9, 81–86, 2007.
]Search in Google Scholar
[
Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269, 604–607, 1977.
]Search in Google Scholar
[
Van Gaal LF, Vansant GA, De Leeuw IH. Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 8, 504–514, 1989.
]Search in Google Scholar
[
Yassine HN, Anderson A, Brinton R, Carmichael O, Espeland MA, Hoscheidt S, Hugenschmidt CE, Keller JN, Peters A, Pi-Sunyer X. Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus? Neurobiol Aging 92, 61–72, 2020.
]Search in Google Scholar
